278 related articles for article (PubMed ID: 16836717)
1. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
Anderson ME
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
[No Abstract] [Full Text] [Related]
2. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
3. RSD-1235. Cardiome.
Billman GE
Curr Opin Investig Drugs; 2003 Mar; 4(3):352-4. PubMed ID: 12735238
[TBL] [Abstract][Full Text] [Related]
4. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
[TBL] [Abstract][Full Text] [Related]
5. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
Cosío FG; Delpón E
Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
[No Abstract] [Full Text] [Related]
6. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
Nattel S; Dobrev D
J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
[No Abstract] [Full Text] [Related]
7. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
8. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge.
Veeraraghavan R; Poelzing S
Cardiovasc Res; 2008 Mar; 77(4):749-56. PubMed ID: 18056761
[TBL] [Abstract][Full Text] [Related]
10. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
11. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
Hinneburg I
Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
[TBL] [Abstract][Full Text] [Related]
12. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation.
Machida T; Hashimoto N; Kuwahara I; Ogino Y; Matsuura J; Yamamoto W; Itano Y; Zamma A; Matsumoto R; Kamon J; Kobayashi T; Ishiwata N; Yamashita T; Ogura T; Nakaya H
Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):94-102. PubMed ID: 21156770
[TBL] [Abstract][Full Text] [Related]
13. Smoothing the Bumpy Road to Antiarrhythmic Drug Development.
Robinson VM; Kowey PR
Circulation; 2015 Dec; 132(23):2195-7. PubMed ID: 26499961
[No Abstract] [Full Text] [Related]
14. Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We?
El-Haou S; Ford JW; Milnes JT
J Cardiovasc Pharmacol; 2015 Nov; 66(5):412-31. PubMed ID: 25978691
[TBL] [Abstract][Full Text] [Related]
15. Why amiodarone is better: another piece of the puzzle.
Murray KT
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):811-2. PubMed ID: 19460071
[No Abstract] [Full Text] [Related]
16. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
Neumann T; Hölschermann H
Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
[No Abstract] [Full Text] [Related]
17. Medical management of atrial fibrillation: future directions.
Page RL
Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
[TBL] [Abstract][Full Text] [Related]
18. Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
Kalifa J; Bernard M; Gout B; Bril A; Cozma D; Laurent P; Chalvidan T; Deharo JC; Djiane P; Cozzone P; Maixent JM
Cardiovasc Drugs Ther; 2007 Feb; 21(1):47-53. PubMed ID: 17356910
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.
Shinagawa K; Derakhchan K; Nattel S
Pacing Clin Electrophysiol; 2003 Mar; 26(3):752-64. PubMed ID: 12698678
[TBL] [Abstract][Full Text] [Related]
20. Safe and effective pharmacologic management of arrhythmias.
Razavi M
Tex Heart Inst J; 2005; 32(2):209-11. PubMed ID: 16107117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
